This clinical trial is focused on studying the effects of a medication called colchicine in patients who have been diagnosed with acute myocarditis. Acute myocarditis is a condition where the heart muscle becomes inflamed, often leading to symptoms like chest pain, heart failure, or palpitations. The study aims to see if colchicine can help reduce the damage to the heart muscle as seen on a special type of heart scan called Cardiac Magnetic Resonance (CMR) and improve overall heart health outcomes.
Participants in the study will receive either colchicine or a placebo, which is a substance with no active medication. The study will last for about six months, during which time the effects of colchicine on heart health will be closely monitored. This includes looking at changes in heart muscle damage and any heart-related symptoms or events that occur during the study period. The goal is to determine if colchicine can effectively reduce heart inflammation and improve the condition of patients with acute myocarditis.
Throughout the study, various health markers will be assessed, such as heart function and any side effects related to colchicine. The study will also track any serious health events, like heart failure or the need for heart-related medical procedures. By the end of the study, researchers hope to gather valuable information on whether colchicine can be a beneficial treatment for those suffering from acute myocarditis.
France 
